Results 1 - 20 of 295 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Refined by:
Journal Title:
Annals Of Oncology
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinomaAnnals of oncology, 2021-05, Vol.32 (5), p.609-619 [Peer Reviewed Journal]2021 ;Copyright © 2021. Published by Elsevier Ltd. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.02.005 ;PMID: 33610734Full text available |
| 2 |
Material Type: Article
|
|
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)Annals of oncology, 2016-08, Vol.27 (8), p.1492-1504 [Peer Reviewed Journal]2016 European Society for Medical Oncology ;The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw217 ;PMID: 27207108Full text available |
| 3 |
Material Type: Article
|
|
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paperAnnals of oncology, 2016-04, Vol.27 (4), p.559-574 [Peer Reviewed Journal]2015 European Society for Medical Oncology ;The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdv623 ;PMID: 26715621Full text available |
| 4 |
Material Type: Article
|
|
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumabAnnals of oncology, 2017-02, Vol.28 (2), p.368-376 [Peer Reviewed Journal]2016 European Society for Medical Oncology ;The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw443 ;PMID: 27687304Full text available |
| 5 |
Material Type: Article
|
|
Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studiesAnnals of oncology, 2017-08, Vol.28 (8), p.1862-1868 [Peer Reviewed Journal]2017 THE AUTHORS ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2017 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx119 ;PMID: 28449055Full text available |
| 6 |
Material Type: Article
|
|
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trialsAnnals of oncology, 2015-01, Vol.26 (1), p.13-21 [Peer Reviewed Journal]2015 European Society for Medical Oncology ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu378 ;PMID: 25115304Full text available |
| 7 |
Material Type: Article
|
|
Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 studyAnnals of oncology, 2017-12, Vol.28 (12), p.3044-3050 [Peer Reviewed Journal]2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2017 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx518 ;PMID: 28950298Full text available |
| 8 |
Material Type: Article
|
|
Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapyAnnals of oncology, 2016-03, Vol.27 (3), p.434-441 [Peer Reviewed Journal]2015 European Society for Medical Oncology ;The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdv622 ;PMID: 26712903Full text available |
| 9 |
Material Type: Article
|
|
Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumorsAnnals of oncology, 2017-08, Vol.28 (8), p.2002-2008 [Peer Reviewed Journal]2017 THE AUTHORS ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2017 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx235 ;PMID: 28520840Full text available |
| 10 |
Material Type: Article
|
|
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?Annals of oncology, 2015-09, Vol.26 (9), p.1813-1823 [Peer Reviewed Journal]2015 European Society for Medical Oncology ;The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdv209 ;PMID: 25922066Full text available |
| 11 |
Material Type: Article
|
|
Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literatureAnnals of oncology, 2017-02, Vol.28 (2), p.377-385 [Peer Reviewed Journal]2016 European Society for Medical Oncology ;The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw558 ;PMID: 28426103Full text available |
| 12 |
Material Type: Article
|
|
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumorsAnnals of oncology, 2017-04, Vol.28 (4), p.855-861 [Peer Reviewed Journal]2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2017 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx002 ;PMID: 28119295Full text available |
| 13 |
Material Type: Article
|
|
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatmentAnnals of oncology, 2017-07, Vol.28 (7), p.1532-1539 [Peer Reviewed Journal]2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx183 ;PMID: 28407039Full text available |
| 14 |
Material Type: Article
|
|
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II studyAnnals of oncology, 2013-07, Vol.24 (7), p.1813-1821 [Peer Reviewed Journal]2013 European Society for Medical Oncology ;2014 INIST-CNRS ;The Author 2013. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2013 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdt107 ;PMID: 23535954Full text available |
| 15 |
Material Type: Article
|
|
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II studyAnnals of oncology, 2010-08, Vol.21 (8), p.1712-1717 [Peer Reviewed Journal]2010 European Society for Medical Oncology ;2015 INIST-CNRS ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdq013 ;PMID: 20147741Full text available |
| 16 |
Material Type: Article
|
|
Biomarkers associated with checkpoint inhibitorsAnnals of oncology, 2016-07, Vol.27 (7), p.1199-1206 [Peer Reviewed Journal]2016 European Society for Medical Oncology ;The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw181 ;PMID: 27122549Full text available |
| 17 |
Material Type: Article
|
|
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case–control studyAnnals of oncology, 2017-12, Vol.28 (12), p.3009-3014 [Peer Reviewed Journal]2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx546 ;PMID: 29045518Full text available |
| 18 |
Material Type: Article
|
|
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatmentAnnals of oncology, 2010-05, Vol.21 (suppl-5), p.v93-v97 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdq222 ;PMID: 20555112Full text available |
| 19 |
Material Type: Article
|
|
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)Annals of oncology, 2019-02, Vol.30 (2), p.161-165 [Peer Reviewed Journal]2018 THE AUTHORS ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdy553 ;PMID: 30624547Full text available |
| 20 |
Material Type: Article
|
|
Nivolumab-induced cholangitic liver disease: a novel form of serious liver injuryAnnals of oncology, 2017-03, Vol.28 (3), p.671-672 [Peer Reviewed Journal]2016 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw649 ;PMID: 27993797Full text available |
Results 1 - 20 of 295 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 1998 (8)
- 1998 To 2002 (40)
- 2003 To 2007 (68)
- 2008 To 2013 (124)
- After 2013 (56)
-
More options
Subject
- Humans (293)
- Oncology (271)
- Life Sciences & Biomedicine (267)
- Science & Technology (267)
- Biological And Medical Sciences (164)
- Medical Sciences (162)
- Pharmacology. Drug Treatments (152)
- Antineoplastic Agents (151)
- Female (150)
- Antineoplastic Agents - Therapeutic Use (146)
- Antibodies, Monoclonal, Humanized (126)
- Middle Aged (107)
- Male (102)
- Aged (89)
- Treatment Outcome (88)
- Adult (85)
- Antibodies, Monoclonal - Adverse Effects (76)
- Tumors (72)
- Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use (69)
-
More options
Databases
Language
- Japanese (49)
- Russian (1)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||